India · Delayed Price · Currency is INR Dr. Agarwal's Health Care Statistics
Total Valuation
NSE:AGARWALEYE has a market cap or net worth of INR 153.61 billion. The enterprise value is 162.40 billion.
| Market Cap | 153.61B |
| Enterprise Value | 162.40B |
Important Dates
The next estimated earnings date is Monday, August 3, 2026.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:AGARWALEYE has 316.96 million shares outstanding. The number of shares has increased by 6.27% in one year.
| Current Share Class | 316.96M |
| Shares Outstanding | 316.96M |
| Shares Change (YoY) | +6.27% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 28.95% |
| Owned by Institutions (%) | 11.41% |
| Float | 60.39M |
Valuation Ratios
The trailing PE ratio is 115.94 and the forward PE ratio is 83.04. NSE:AGARWALEYE's PEG ratio is 2.24.
| PE Ratio | 115.94 |
| Forward PE | 83.04 |
| PS Ratio | 7.38 |
| PB Ratio | 7.25 |
| P/TBV Ratio | 17.60 |
| P/FCF Ratio | 216.24 |
| P/OCF Ratio | 29.60 |
| PEG Ratio | 2.24 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.51, with an EV/FCF ratio of 228.61.
| EV / Earnings | 121.93 |
| EV / Sales | 7.81 |
| EV / EBITDA | 28.51 |
| EV / EBIT | 55.37 |
| EV / FCF | 228.61 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.24 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 1.87 |
| Debt / FCF | 15.01 |
| Interest Coverage | 3.24 |
Financial Efficiency
Return on equity (ROE) is 8.31% and return on invested capital (ROIC) is 7.20%.
| Return on Equity (ROE) | 8.31% |
| Return on Assets (ROA) | 4.82% |
| Return on Invested Capital (ROIC) | 7.20% |
| Return on Capital Employed (ROCE) | 8.43% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.55 |
| Inventory Turnover | 13.26 |
Taxes
In the past 12 months, NSE:AGARWALEYE has paid 805.00 million in taxes.
| Income Tax | 805.00M |
| Effective Tax Rate | 32.38% |
Stock Price Statistics
The stock price has increased by +19.59% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +19.59% |
| 50-Day Moving Average | 457.49 |
| 200-Day Moving Average | 471.09 |
| Relative Strength Index (RSI) | 67.70 |
| Average Volume (20 Days) | 75,491 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AGARWALEYE had revenue of INR 20.80 billion and earned 1.33 billion in profits. Earnings per share was 4.18.
| Revenue | 20.80B |
| Gross Profit | 9.24B |
| Operating Income | 2.93B |
| Pretax Income | 2.49B |
| Net Income | 1.33B |
| EBITDA | 5.70B |
| EBIT | 2.93B |
| Earnings Per Share (EPS) | 4.18 |
Balance Sheet
The company has 2.82 billion in cash and 10.66 billion in debt, with a net cash position of -7.85 billion or -24.76 per share.
| Cash & Cash Equivalents | 2.82B |
| Total Debt | 10.66B |
| Net Cash | -7.85B |
| Net Cash Per Share | -24.76 |
| Equity (Book Value) | 21.20B |
| Book Value Per Share | 63.76 |
| Working Capital | 1.11B |
Cash Flow
In the last 12 months, operating cash flow was 5.19 billion and capital expenditures -4.48 billion, giving a free cash flow of 710.40 million.
| Operating Cash Flow | 5.19B |
| Capital Expenditures | -4.48B |
| Depreciation & Amortization | 2.76B |
| Net Borrowing | -2.23B |
| Free Cash Flow | 710.40M |
| FCF Per Share | 2.24 |
Margins
Gross margin is 44.44%, with operating and profit margins of 14.10% and 6.40%.
| Gross Margin | 44.44% |
| Operating Margin | 14.10% |
| Pretax Margin | 11.95% |
| Profit Margin | 6.40% |
| EBITDA Margin | 27.38% |
| EBIT Margin | 14.10% |
| FCF Margin | 3.42% |
Dividends & Yields
NSE:AGARWALEYE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.82% |
| Buyback Yield | -6.27% |
| Shareholder Yield | -6.27% |
| Earnings Yield | 0.87% |
| FCF Yield | 0.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:AGARWALEYE is 545.00, which is 13.29% higher than the current price. The consensus rating is "Buy".
| Price Target | 545.00 |
| Price Target Difference | 13.29% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 20.45% |
| EPS Growth Forecast (3Y) | 40.44% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |